Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$116.64 USD

116.64
9,931,171

+2.50 (2.19%)

Updated Aug 21, 2026 04:02 PM ET

After-Market: $116.52 -0.12 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (96 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kinjel Shah headshot

J&J's MedTech Unit Sales Improve: Will the Momentum Last?

by Kinjel Shah

J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Moumi Mondal headshot

Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?

by Moumi Mondal

BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.

Zacks Equity Research

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

by Zacks Equity Research

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Moumi Mondal headshot

HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?

by Moumi Mondal

Hologic's $18.3B buyout deal and Abbott's strong growth across key segments set up a close contest for MedTech investors.

Zacks Equity Research

The Zacks Analyst Blog Highlights International Business Machines, Micron and Abbott

by Zacks Equity Research

Zacks analysts highlight IBM, Micron, and Abbott for their innovation-driven growth, solid fundamentals, and evolving market strategies.

Mark Vickery headshot

Top Stock Reports for IBM, Micron & Abbott

by Mark Vickery

IBM posts strong Q3 results as Watsonx and quantum bets boost growth, while Micron rides AI-driven memory demand and Abbott expands on device strength.

Zacks Equity Research

Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?

by Zacks Equity Research

DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.

Zacks Equity Research

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

by Zacks Equity Research

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Urmimala Biswas headshot

Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains

by Urmimala Biswas

Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.

Zacks Equity Research

Company News for Oct 16, 2025

by Zacks Equity Research

Companies In The News Are: HWC, PGR, ABT, ASML.